Peter Raddatz

570 total citations
30 papers, 445 citations indexed

About

Peter Raddatz is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Raddatz has authored 30 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Raddatz's work include Chemical Synthesis and Analysis (7 papers), Synthetic Organic Chemistry Methods (7 papers) and Asymmetric Synthesis and Catalysis (6 papers). Peter Raddatz is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Synthetic Organic Chemistry Methods (7 papers) and Asymmetric Synthesis and Catalysis (6 papers). Peter Raddatz collaborates with scholars based in Germany, United States and Switzerland. Peter Raddatz's co-authors include Ekkehard Winterfeldt, Michael Harré, Joachim Gante, Klaus-Otto Minck, Thomas Kissel, Friedrich Rippmann, Claus J. Schmitges, A. Jonczyk, Ulrich Koert and Alfred Jonczyk and has published in prestigious journals such as Journal of Medicinal Chemistry, Chemistry - A European Journal and Tetrahedron.

In The Last Decade

Peter Raddatz

28 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Raddatz Germany 14 239 185 48 41 32 30 445
Barry Porter United Kingdom 13 297 1.2× 208 1.1× 37 0.8× 10 0.2× 21 0.7× 31 535
Joseph Sisko United States 15 627 2.6× 280 1.5× 39 0.8× 51 1.2× 16 0.5× 27 849
Stephen E. de Laszlo United States 16 482 2.0× 394 2.1× 41 0.9× 76 1.9× 10 0.3× 28 786
Daniele M. Leonard United States 12 178 0.7× 323 1.7× 107 2.2× 28 0.7× 11 0.3× 17 481
John W. Butcher United States 11 199 0.8× 180 1.0× 33 0.7× 17 0.4× 11 0.3× 14 407
M. Jonathan Fray United Kingdom 15 376 1.6× 253 1.4× 70 1.5× 13 0.3× 24 0.8× 47 672
Alberto Bargiotti Italy 12 232 1.0× 293 1.6× 143 3.0× 44 1.1× 15 0.5× 20 587
Hwa-Ok Kim United States 14 316 1.3× 306 1.7× 49 1.0× 10 0.2× 28 0.9× 32 520
Allan Hallett United Kingdom 12 227 0.9× 405 2.2× 67 1.4× 72 1.8× 17 0.5× 17 621
Julián Priego Spain 16 701 2.9× 234 1.3× 25 0.5× 15 0.4× 11 0.3× 43 865

Countries citing papers authored by Peter Raddatz

Since Specialization
Citations

This map shows the geographic impact of Peter Raddatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Raddatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Raddatz more than expected).

Fields of papers citing papers by Peter Raddatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Raddatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Raddatz. The network helps show where Peter Raddatz may publish in the future.

Co-authorship network of co-authors of Peter Raddatz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Raddatz. A scholar is included among the top collaborators of Peter Raddatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Raddatz. Peter Raddatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koert, Ulrich, et al.. (2004). Dianhydrohexitole-Based Benzamidines: An Efficient Synthesis of New Factor Xa Inhibitors. Synthesis. 2004(8). 1211–1228. 4 indexed citations
2.
Osterkamp, Frank, et al.. (2000). Synthesis and Biological Evaluation of Integrin Antagonists Containingtrans- andcis-2,5-Disubstituted THF Rings. Chemistry - A European Journal. 6(4). 666–683. 25 indexed citations
3.
Kamm, Walter, et al.. (2000). Evaluation of absorption enhancement for a potent cyclopeptidic ανβ3-antagonist in a human intestinal cell line (Caco-2). European Journal of Pharmaceutical Sciences. 10(3). 205–214. 27 indexed citations
4.
Kamm, Walter, Peter Raddatz, Joachim Gante, & Thomas Kissel. (1999). Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.. Pharmaceutical Research. 16(10). 1527–1533. 8 indexed citations
5.
Fischer, Holger, Anna Seelig, N. F. Beier, Peter Raddatz, & Joachim Seelig. (1999). New Drugs for the Na + /H + Exchanger. Influence of Na + Concentration and Determination of Inhibition Constants with a Microphysiometer. The Journal of Membrane Biology. 168(1). 39–45. 27 indexed citations
6.
Gante, Joachim, et al.. (1996). New antithrombotic RGD-mimetics with high bioavailability. Bioorganic & Medicinal Chemistry Letters. 6(20). 2425–2430. 13 indexed citations
7.
Walter, Elke, Thomas Kissel, & Peter Raddatz. (1995). Transport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Route. Pharmaceutical Research. 12(11). 1801–1805. 14 indexed citations
8.
Raddatz, Peter & Joachim Gante. (1995). Review Cardiovascular & Renal; Recent Developments in Glycoprotein llb/llla Antagonists. Expert Opinion on Therapeutic Patents. 5(11). 1165–1183. 14 indexed citations
9.
Gante, Joachim, et al.. (1995). New peptidomimetics in the chemistry of fibrinogen receptor antagonists. Letters in Peptide Science. 2(3-4). 135–140. 9 indexed citations
10.
Raddatz, Peter, et al.. (1994). Non-peptide Renin Inhibitors Containing 2-(((3-Phenylpropyl)phosphoryl)oxy)alkanoic Acid Moieties as P2-P3 Replacements. Journal of Medicinal Chemistry. 37(4). 486–497. 16 indexed citations
11.
Raddatz, Peter. (1994). Overview Cardiovascular & Renal: Recent developments in renin inhibitors: part 1. Expert Opinion on Therapeutic Patents. 4(5). 489–504. 9 indexed citations
12.
Raddatz, Peter. (1994). Overview Cardiovascular & Renal: Recent developments in renin inhibitors: part II. Expert Opinion on Therapeutic Patents. 4(11). 1347–1359. 8 indexed citations
13.
Raddatz, Peter, et al.. (1992). Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'. Journal of Medicinal Chemistry. 35(19). 3525–3536. 17 indexed citations
14.
Raddatz, Peter, et al.. (1991). Substrate Analogue Renin Inhibitors Containing Replacements of Histidine in P2 or Isosteres of the Amide Bond Between P3 and P2 Sites. Advances in experimental medicine and biology. 306. 387–390. 5 indexed citations
15.
Raddatz, Peter, et al.. (1991). Substrate analog renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites. Journal of Medicinal Chemistry. 34(11). 3267–3280. 33 indexed citations
16.
Raddatz, Peter, et al.. (1988). Reduktion mit Hefezellen, der Schlüsselschritt einer effizienten Synthese von (3S,4S)‐4‐Amino‐3‐hydroxypentansäuren. Angewandte Chemie. 100(3). 414–415. 4 indexed citations
17.
Raddatz, Peter, et al.. (1986). ChemInform Abstract: Computer‐Graphics Methods in Pharmaceutical Research: Visualisation of Renin Inhibitor Complexes. Chemischer Informationsdienst. 17(23). 2 indexed citations
18.
Raddatz, Peter & Ekkehard Winterfeldt. (1981). The Stereospecificity of Brefeldin A Cyclization. Angewandte Chemie International Edition in English. 20(3). 286–287. 10 indexed citations
19.
Raddatz, Peter & Ekkehard Winterfeldt. (1981). Die Stereospezifität der Brefeldin‐A‐Cyclisierung. Angewandte Chemie. 93(3). 281–282. 7 indexed citations
20.
Raddatz, Peter, et al.. (1980). Ein neuer Weg zu Brefeldin A. Angewandte Chemie. 92(6). 486–487. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Porter Breakdown of academic impact, for papers by Joseph Sisko Breakdown of academic impact, for papers by Stephen E. de Laszlo Breakdown of academic impact, for papers by Daniele M. Leonard Breakdown of academic impact, for papers by John W. Butcher Breakdown of academic impact, for papers by M. Jonathan Fray Breakdown of academic impact, for papers by Alberto Bargiotti Breakdown of academic impact, for papers by Hwa-Ok Kim Breakdown of academic impact, for papers by Allan Hallett Breakdown of academic impact, for papers by Julián Priego
Rankless by CCL
2026